ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Methadone Maintenance for Prisoners (MMP)

This study has been completed.

Sponsored by: National Institute on Drug Abuse (NIDA)
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00378079
  Purpose

This five-year study examines the benefits of methadone maintenance treatment initiated in prison and continued in the community to male offenders who were previously, but not currently, heroin-dependent. It is anticipated that such prisoners will have more favorable outcomes in the year following release with regard to drug abuse, crime, and HIV risk behavior than either prisoners who receive counseling only or begin initiation of methadone maintenance in the community


Condition Intervention Phase
Heroin Addiction
Other: Counseling Only
Drug: Counseling + Transfer
Drug: Counseling + Methadone
Phase III

MedlinePlus related topics:   Heroin   

ChemIDplus related topics:   Methadone    Methadone hydrochloride   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Parallel Assignment
Official Title:   Methadone Maintenance for Prisoners

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • treatment entry and retention in the community [ Time Frame: one year ] [ Designated as safety issue: No ]
  • heroin use [ Time Frame: one year ] [ Designated as safety issue: No ]
  • cocaine use [ Time Frame: one year ] [ Designated as safety issue: No ]
  • HIV-risk behaviors [ Time Frame: one year ] [ Designated as safety issue: No ]
  • criminal activity [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • employment [ Time Frame: one year ] [ Designated as safety issue: No ]

Enrollment:   211
Study Start Date:   September 2003
Study Completion Date:   January 2008
Primary Completion Date:   January 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
3: Experimental Drug: Counseling + Methadone
Counseling and methadone maintenance in prison, with opportunity to continue that treatment upon release
1: Active Comparator Other: Counseling Only
Counseling only in prison, with passive referral to drug abuse treatment upon release
2: Experimental Drug: Counseling + Transfer
Counseling only in prison, with opportunity to enter methadone maintenance upon release

Detailed Description:

Most prisoners with histories of pre-incarceration heroin addiction do not receive treatment while incarcerated or upon release. Effective treatment for such prisoners is urgently needed because rapid relapse typically follows release. Relapse is associated with increased risk for HIV, overdose death, criminal activity, and reincarceration. Other than three studies of methadone maintenance with short-term jail inmates, the only study of longer-term inmates who were previously, but not currently, heroin-dependent was the investigator's pilot study with pre-release inmates. Based on that pilot study, which found that initiating maintenance treatment is feasible and facilitates post-release treatment entry, the present study provides a more rigorous examination of this unique treatment approach.

  Eligibility
Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Heroin dependence in the year prior to current incarceration
  • 3-6 months left to serve in prison-male pre-release inmate suitability for methadone maintenance as determined by medical evaluation
  • Willingness to enroll in methadone maintenance
  • Having a Baltimore address

Exclusion Criteria:

  • Pending parole hearing
  • Pending charges
  • Kidney failure
  • Liver failure
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00378079

Locations
United States, Maryland
Metropolitan Transition Center    
      Baltimore, Maryland, United States, 21201

Sponsors and Collaborators

Investigators
Principal Investigator:     Timothy W Kinlock, Ph.D.     Friends Research Institute, Inc.    
  More Information


Publications of Results:
Kinlock TW, Gordon MS, Schwartz RP, O'Grady K, Fitzgerald TT, Wilson M. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release. Drug Alcohol Depend. 2007 Dec 1;91(2-3):220-7. Epub 2007 Jul 12.
 
Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-reelase. Addiction 103:1333-1342,2008
 

Responsible Party:   Friends Research Institute ( Timothy W. Kinlock, Ph.D., Principal Investigator )
Study ID Numbers:   1 RO1 DA 16237-03
First Received:   September 15, 2006
Last Updated:   August 8, 2008
ClinicalTrials.gov Identifier:   NCT00378079
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Naphazoline
Oxymetazoline
Methadone
Behavior, Addictive
Guaifenesin
Phenylephrine
Mental Disorders
Heroin Dependence
Substance-Related Disorders
Disorders of Environmental Origin
Phenylpropanolamine
Opioid-Related Disorders

Additional relevant MeSH terms:
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Analgesics
Antitussive Agents
Central Nervous System Agents
Analgesics, Opioid
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 17, 2008




Links to all studies - primarily for crawlers